Precision Optics Corporation, Inc.
Company & revenue
About Precision Optics Corporation, Inc.
Who they are
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers.
Detailed revenue, brand and relationship research has not yet been completed for POCI.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
33
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
47
Weak
Financial Strength
37
Business Quality / Moat
81
Management
40
Growth Quality
45
Risk / Durability
9
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
40
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
47/100
Building Historical Record
Model Score 47/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently sees meaningful weaknesses in the company-strength profile.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Asset quality scores strongly
- •Insider activity signal is favorable
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for POCI
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can POCI maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can POCI fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is POCI likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What specifically needs to improve for POCI to reach sustainable profitability?
- •What future growth or profitability would be needed to justify POCI's current valuation?
Essential Investment Snapshot
Wall Street Score
33
Opportunity Score
40
Market Cap
$48.8M
P/E Ratio
-9.0
EPS
$-0.46
52-Week High
$6.15
52-Week Low
$3.55
Beta
0.32
Shares Outstanding
8.5M
Total Revenue
$31.5M
Total Debt
$4.1M
Dividend
No current dividend
Liquidation Value / Share
$2.39
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Neutral / mixed momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for POCI
Detected from reported data — verify before acting.Debt service risk
Interest coverage is low (~-23.7x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on POCI.
What the Bulls Say
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Product opportunity: Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature.
What the Bears Say
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Instruments & Supplies industry.
- −Diluted weighted-average shares increased 25.6% year over year.
- −Negative free cash flow may increase the need for outside financing and dilution.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
7 historical score records availablePrevious Score
33
Sep 29, 2026
Change
Unchanged
Current Score
33
Oct 1, 2026
Category Changes
POCI score was unchanged.
Projected Score
Projected Score
35
Projected Change
+2.0%
Preliminary comparable-period financial changes suggest improvement of approximately 2.0 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$4.46
Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Related Companies
Medical - Instruments & SuppliesNews
Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference
Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript
Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Reviewing IceCure Medical (NASDAQ:ICCM) & Precision Optics (NASDAQ:POCI)
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial